Literature DB >> 26152471

Factors Associated With Quality of Life in Subjects With Stable COPD.

Aydanur Ekici1, Emel Bulcun2, Tulay Karakoc1, Erol Senturk1, Mehmet Ekici1.   

Abstract

BACKGROUND: The purpose of this study was to assess the impact of bronchiectasis, anxiety and depression, and parameters of disease severity on health-related quality of life (HRQOL) in subjects with COPD.
METHODS: Sixty-two subjects with stable COPD were selected for the study. The presence of bronchiectasis in all subjects with COPD was investigated by high-resolution computed tomography. Pulmonary function tests were performed. Dyspnea was assessed using the Modified Medical Research Council (MMRC) dyspnea scale. Psychological disorders were investigated using the Hospital Anxiety and Depression Scale (HADS), and the HRQOL was examined using the St George Respiratory Questionnaire (SGRQ).
RESULTS: High-resolution computed tomography revealed that 44 of 62 (70.9%) subjects with COPD had bronchiectasis. There were no differences in pulmonary function tests, symptoms, activities, impact, SGRQ total scores, and HADS scores between COPD subjects with and without bronchiectasis. Pearson correlation analyses showed that there was no significant association between the presence of bronchiectasis, bronchial wall thickness, or severity of bronchial dilatation and all subscales of the SGRQ or HADS scores. Additionally, HADS scores showed significant positive association with all subscales of the SGRQ in all subjects. In linear regression analysis, a statistically significant relationship was found between the SGRQ total score and percent-of-predicted FEV1, percent-of-predicted diffusing capacity of the lung for carbon monoxide, MMRC score, and anxiety score, but the SGRQ total score was not associated with age, body mass index, total number of hospitalizations, PaO2 , or depression score.
CONCLUSIONS: The presence of bronchiectasis in subjects with COPD does not impact HRQOL and psychological disorders. However, disease severity, dyspnea levels, and anxiety scores predict poor HRQOL.
Copyright © 2015 by Daedalus Enterprises.

Entities:  

Keywords:  anxiety; bronchiectasis; chronic obstructive pulmonary disease (COPD); depression; health-related quality of life (HRQOL)

Mesh:

Year:  2015        PMID: 26152471     DOI: 10.4187/respcare.03904

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  6 in total

1.  Self-management and health related quality of life in persons with chronic obstructive pulmonary disease.

Authors:  Heidi B Bringsvor; Eva Langeland; Bjørg Frøysland Oftedal; Knut Skaug; Jörg Assmus; Signe Berit Bentsen
Journal:  Qual Life Res       Date:  2019-06-18       Impact factor: 4.147

Review 2.  Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Perspectives on the Use of Hypnosis.

Authors:  Hernán Anlló; François Larue; Bertrand Herer
Journal:  Front Psychol       Date:  2022-05-19

3.  Validity and Reliability of Turkish Version of Reaction Type Scale Against COPD.

Authors:  Nermin Gürhan; Selma Aydoğan Eroğlu; Ülkü Polat; Emel Kaya; Nurdan Köktürk; Burak Şirin; Hakan Günen
Journal:  Turk Thorac J       Date:  2021-09

4.  Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013.

Authors:  Derek Weycker; Gary L Hansen; Frederic D Seifer
Journal:  Chron Respir Dis       Date:  2017-05-30       Impact factor: 2.444

5.  Impact of Exercise Capacity Upon Respiratory Functions, Perception of Dyspnea, and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease.

Authors:  Wenjun Liu; Yufei Liu; Xiaolin Li
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-06-01

6.  Chronic obstructive pulmonary disease, bronchial asthma and allergic rhinitis in the adult population within the commonwealth of independent states: rationale and design of the CORE study.

Authors:  Yuriy Feshchenko; Liudmyla Iashyna; Damilya Nugmanova; Olga Gyrina; Maryna Polianska; Alexander Markov; Maryna Moibenko; Janina Makarova; Luqman Tariq; Marcelo Horacio S Pereira; Eljan Mammadbayov; Irada Akhundova; Averyan Vasylyev
Journal:  BMC Pulm Med       Date:  2017-10-10       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.